{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:03:10Z","timestamp":1790215390668,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115211","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:41:18Z","timestamp":1785166878000},"page":"115211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering the blood: Lipid nanoparticle platforms for ex vivo immune and hematopoietic cell therapies"],"prefix":"10.1016","volume":"398","author":[{"given":"Yongjoo","family":"Byeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuoya","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Bee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunbin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayoung","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Badior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J.","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyukjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-019-0052-1","article-title":"NK cells for cancer immunotherapy","volume":"19","author":"Shimasaki","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","article-title":"Gene therapy using haematopoietic stem and progenitor cells","volume":"22","author":"Ferrari","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115211_bb0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"issue":"Pt A","key":"10.1016\/j.jconrel.2026.115211_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.addr.2016.02.007","article-title":"Red blood cells: supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems","volume":"106","author":"Villa","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115211_bb0025","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther Oncolyt."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115211_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413685","article-title":"Current non-viral-based strategies to manufacture CAR-T cells","volume":"25","author":"Gehrke","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115211_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122683","article-title":"The paths toward non-viral CAR-T cell manufacturing: a comprehensive review of state-of-the-art methods","volume":"348","author":"Metanat","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/10915818251318248","article-title":"Mutagenesis and carcinogenesis risk evaluation for AAV and lentiviral gene therapies","volume":"44","author":"Parman","year":"2025","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0045","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2015.12.032","article-title":"Materials for non-viral intracellular delivery of messenger RNA therapeutics","volume":"240","author":"Kauffman","year":"2016","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115211_bb0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.2022019333","article-title":"Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells","volume":"142","author":"Vavassori","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0055","first-page":"1815","article-title":"DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways","volume":"14","author":"Nelson","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115211_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2023.1148693","article-title":"Current approaches and potential challenges in the delivery of gene editing cargos into hematopoietic stem and progenitor cells","volume":"5","author":"Murugesan","year":"2023","journal-title":"Front. Genome Ed."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.stem.2019.02.019","article-title":"Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response","volume":"24","author":"Schiroli","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115211_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4155\/tde-2016-0006","article-title":"mRNA vaccine delivery using lipid nanoparticles","volume":"7","author":"Reichmuth","year":"2016","journal-title":"Ther. Deliv."},{"issue":"Pt A","key":"10.1016\/j.jconrel.2026.115211_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115211_bb0090","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2004.12.018","article-title":"Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency","volume":"11","author":"Zuhorn","year":"2005","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115211_bb0095","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1021\/acs.nanolett.2c01133","article-title":"Universal barcoding predicts in vivo ApoE-independent lipid nanoparticle delivery","volume":"22","author":"Da Silva Sanchez","year":"2022","journal-title":"Nano Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115211_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10556","article-title":"Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety","volume":"8","author":"Kim","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.115211_bb0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"issue":"34","key":"10.1016\/j.jconrel.2026.115211_bb0110","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"43","key":"10.1016\/j.jconrel.2026.115211_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady5579","article-title":"A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell-targeted delivery of gene-editing proteins","volume":"11","author":"Lu","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0120","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115211_bb0125","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3389\/fphys.2017.01076","article-title":"From erythroblasts to mature red blood cells: organelle clearance in mammals","volume":"8","author":"Moras","year":"2017","journal-title":"Front. Physiol."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115211_bb0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319856121","article-title":"IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation","volume":"121","author":"Tilsed","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5373","key":"10.1016\/j.jconrel.2026.115211_bb0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115211_bb0140","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0145","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9967","key":"10.1016\/j.jconrel.2026.115211_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.115211_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.865424","article-title":"Review: sustainable clinical development of CAR-T cells - switching from viral transduction towards CRISPR-Cas gene editing","volume":"13","author":"Wagner","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101139","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115211_bb0170","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMp2400209","article-title":"Secondary cancers after chimeric antigen receptor T-cell therapy","volume":"390","author":"Verdun","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115211_bb0175","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa2402730","article-title":"Aggressive lymphoma after CD19 CAR T-cell therapy","volume":"391","author":"Kobbe","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0180","article-title":"The design of retroviral vectors used in the CAR-T products, risk management, and future perspective","volume":"6","author":"Yin","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jconrel.2026.115211_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105834","article-title":"Viral and non-viral vectors in gene therapy: current state and clinical perspectives","volume":"118","author":"Geng","year":"2025","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202304378","article-title":"In vivo mRNA CAR T cell engineering via targeted ionizable lipid nanoparticles with extrahepatic tropism","volume":"20","author":"Billingsley","year":"2024","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0195","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0200","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of lipid nanoparticles for RNA delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115211_bb0210","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1039\/D4QM00479E","article-title":"Critical considerations of mRNA\u2013LNP technology for CAR-T therapy: components, payloads and emerging horizons","volume":"8","author":"Qu","year":"2024","journal-title":"Mater. Chem. Front."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0215","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.nanolett.9b04246","article-title":"Ionizable lipid nanoparticle-mediated mRNA delivery for human CAR T cell engineering","volume":"20","author":"Billingsley","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.115211_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells","volume":"347","author":"Patel","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0225","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acs.nanolett.1c02503","article-title":"Orthogonal Design of Experiments for optimization of lipid nanoparticles for mRNA engineering of CAR T cells","volume":"22","author":"Billingsley","year":"2022","journal-title":"Nano Lett."},{"issue":"49","key":"10.1016\/j.jconrel.2026.115211_bb0230","doi-asserted-by":"crossref","first-page":"41836","DOI":"10.1021\/acsnano.5c15903","article-title":"Customizable mRNA lipid nanoparticles for transfection of primary human T cells","volume":"19","author":"VanKeulen-Miller","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115211_bb0235","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.copbio.2018.01.025","article-title":"A guide to manufacturing CAR T cell therapies","volume":"53","author":"Vormittag","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0240","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1016\/j.ymthe.2024.09.019","article-title":"Synergistic integration of mRNA-LNP with CAR-engineered immune cells: pioneering progress in immunotherapy","volume":"32","author":"Chen","year":"2024","journal-title":"Mol. Ther."},{"issue":"26","key":"10.1016\/j.jconrel.2026.115211_bb0245","article-title":"Antigen presenting cell mimetic lipid nanoparticles for rapid mRNA CAR T cell cancer immunotherapy","volume":"36","author":"Metzloff","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.115211_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104912","article-title":"Beyond CAR-T: engineered NK cell therapies (CAR-NK, NKCEs) in next-generation cancer immunotherapy","volume":"214","author":"Zhang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841107","article-title":"iPSC-derived natural killer cell therapies - expansion and targeting","volume":"13","author":"Goldenson","year":"2022","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41423-024-01145-x","article-title":"Development of NK cell-based cancer immunotherapies through receptor engineering","volume":"21","author":"Page","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/cei\/uxae045","article-title":"NK-cell receptor modulation in viral infections","volume":"217","author":"Lenart","year":"2024","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0270","article-title":"Lipid nanoparticle mediated delivery of anti-CD19 CAR mRNA to umbilical blood cord NK cells for targeting CD19+ primary B-ALL cells","volume":"74","author":"Salehi-Shadkami","year":"2025","journal-title":"Curr. Res. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102263","article-title":"Enhancing natural killer cells proliferation and cytotoxicity using imidazole-based lipid nanoparticles encapsulating interleukin-2 mRNA","volume":"35","author":"Delehedde","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0280","doi-asserted-by":"crossref","first-page":"18729","DOI":"10.1038\/s41598-019-55239-y","article-title":"Adult peripheral blood and umbilical cord blood NK cells are good sources for effective CAR therapy against CD19 positive leukemic cells","volume":"9","author":"Herrera","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115211_bb0285","article-title":"Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters","volume":"16","author":"Kennedy","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00329","article-title":"Umbilical cord blood natural killer cells, their characteristics, and potential clinical applications","volume":"8","author":"Sarvaria","year":"2017","journal-title":"Front. Immunol."},{"issue":"5 Pt 1","key":"10.1016\/j.jconrel.2026.115211_bb0295","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1203\/01.PDR.0000156501.55431.20","article-title":"Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections","volume":"57","author":"Dalle","year":"2005","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053611","article-title":"GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo","volume":"8","author":"Lim","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115211_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020740","article-title":"Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process","volume":"6","author":"Spanholtz","year":"2011","journal-title":"PLoS One"},{"issue":"8000","key":"10.1016\/j.jconrel.2026.115211_bb0310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115211_bb0315","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.omto.2022.12.006","article-title":"Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations","volume":"28","author":"Allan","year":"2023","journal-title":"Mol Ther Oncolyt."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115211_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050946","article-title":"Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115211_bb0325","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115211_bb0330","doi-asserted-by":"crossref","first-page":"6058147","DOI":"10.1155\/2016\/6058147","article-title":"Tumor-associated macrophages and neutrophils in tumor microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0335","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0340","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/gt.2008.54","article-title":"Immunity to adeno-associated virus vectors in animals and humans: a continued challenge","volume":"15","author":"Zaiss","year":"2008","journal-title":"Gene Ther."},{"issue":"13","key":"10.1016\/j.jconrel.2026.115211_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ads2295","article-title":"Macrophage-targeted Mms6 mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice","volume":"11","author":"Fu","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.115211_bb0350","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mattod.2025.07.028","article-title":"Advances in the rational design of ionizable lipids for mRNA therapeutics","volume":"89","author":"Lee","year":"2025","journal-title":"Mater. Today"},{"issue":"27","key":"10.1016\/j.jconrel.2026.115211_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202312038","article-title":"Oxidized mRNA lipid nanoparticles for in situ chimeric antigen receptor monocyte engineering","volume":"34","author":"Mukalel","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115211_bb0360","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202528","article-title":"Delivering mRNA to secondary lymphoid tissues by phosphatidylserine-loaded lipid nanoparticles","volume":"12","author":"Gomi","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115211_bb0365","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2026.115211_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116930","article-title":"Macrophage polarization in the tumor microenvironment: emerging roles and therapeutic potentials","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115211_bb0375","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ccell.2018.03.027","article-title":"Extrinsic phagocyte-dependent STING signaling dictates the immunogenicity of dying cells","volume":"33","author":"Ahn","year":"2018","journal-title":"Cancer Cell"},{"issue":"48","key":"10.1016\/j.jconrel.2026.115211_bb0380","doi-asserted-by":"crossref","first-page":"40798","DOI":"10.1021\/acsnano.5c09138","article-title":"In situ chimeric antigen receptor macrophage therapy via co-delivery of mRNA and Immunostimulant","volume":"19","author":"Han","year":"2025","journal-title":"ACS Nano"},{"issue":"25","key":"10.1016\/j.jconrel.2026.115211_bb0385","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1039\/D1TB00736J","article-title":"Identification of a potent ionizable lipid for efficient macrophage transfection and systemic anti-interleukin-1beta siRNA delivery against acute liver failure","volume":"9","author":"Ding","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115211_bb0390","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.imbio.2014.05.002","article-title":"Human macrophage polarization in vitro: maturation and activation methods compared","volume":"219","author":"Vogel","year":"2014","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115211_bb0395","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jimmun\/vkae032","article-title":"Comparison of human macrophages derived from peripheral blood and bone marrow","volume":"214","author":"Smith","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.omtm.2021.03.003","article-title":"In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2","volume":"21","author":"Hoffmann","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0405","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41467-017-00448-0","article-title":"Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin","volume":"8","author":"Huang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115211_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114681","article-title":"Engineering red blood cells for antigen-specific immune tolerance and personalized therapy of autoimmune diseases","volume":"392","author":"Yuan","year":"2026","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259353","article-title":"Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity","volume":"16","author":"Deshycka","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.115211_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9060143","article-title":"Platelet activation: the mechanisms and potential biomarkers","volume":"2016","author":"Yun","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2026.115211_bb0425","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3389\/fimmu.2018.02712","article-title":"Role of platelets in leukocyte recruitment and resolution of inflammation","volume":"9","author":"Rossaint","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115211_bb0430","article-title":"The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy","volume":"4","author":"Liao","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.jconrel.2026.115211_bb0435","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omtm.2018.01.011","article-title":"Platelet-targeted gene therapy for hemophilia","volume":"9","author":"Shi","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0440","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.stem.2015.09.015","article-title":"Targeted application of human genetic variation can improve red blood cell production from stem cells","volume":"18","author":"Giani","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115211_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105264","article-title":"Nucleic acid delivery with red-blood-cell-based carriers","volume":"22","author":"Della Pelle","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3b","key":"10.1016\/j.jconrel.2026.115211_bb0450","first-page":"1741","article-title":"Nanoerythrosomes, a new derivative of erythrocyte ghost: IV. Fate of reinjected nanoerythrosomes","volume":"21","author":"D\u00e9silets","year":"2001","journal-title":"Anticancer Res."},{"issue":"48","key":"10.1016\/j.jconrel.2026.115211_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi0508","article-title":"Genetically engineered transfusable platelets using mRNA lipid nanoparticles","volume":"9","author":"Leung","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0460","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1538-7836.2008.03211.x","article-title":"Protein synthesis by platelets: historical and new perspectives","volume":"7","author":"Weyrich","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"21","key":"10.1016\/j.jconrel.2026.115211_bb0465","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood.2024024405","article-title":"Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices","volume":"144","author":"Strong","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2026.115211_bb0470","article-title":"Emerging gene therapies for enhancing the hemostatic potential of platelets","volume":"Supplement","author":"Leung","year":"2021","journal-title":"Trauma Hemost. Oxygen. Res."},{"issue":"21","key":"10.1016\/j.jconrel.2026.115211_bb0475","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1001\/archinte.168.21.2377","article-title":"Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer","volume":"168","author":"Khorana","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0480","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cll.2010.02.002","article-title":"The platelet storage lesion","volume":"30","author":"Devine","year":"2010","journal-title":"Clin. Lab. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0485","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1073\/pnas.76.1.473","article-title":"Incorporation of glucocerebrosidase into Gaucher\u2019s disease monocytes in vitro","volume":"76","author":"Dale","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.jconrel.2026.115211_bb0490","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/bloodadvances.2021005194","article-title":"The RBC\u2019S road to ghost and removal: splenic clearance","volume":"5","author":"Asaro","year":"2021","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115211_bb0495","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0020-7519(01)00258-2","article-title":"Nutrient acquisition by intracellular apicomplexan parasites: staying in for dinner","volume":"31","author":"Saliba","year":"2001","journal-title":"Int. J. Parasitol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0500","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminhematol.2018.04.014","article-title":"Genetic therapies for sickle cell disease","volume":"55","author":"Esrick","year":"2018","journal-title":"Semin. Hematol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115211_bb0505","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic stem cell gene therapy: Progress and lessons learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"23","key":"10.1016\/j.jconrel.2026.115211_bb0510","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1182\/blood-2011-01-283606","article-title":"Ex vivo expansion of human hematopoietic stem and progenitor cells","volume":"117","author":"Dahlberg","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0515","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-021-20909-x","article-title":"Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice","volume":"12","author":"Wilkinson","year":"2021","journal-title":"Nat. Commun."},{"issue":"598","key":"10.1016\/j.jconrel.2026.115211_bb0520","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf2444","article-title":"Development of \u03b2-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease","volume":"13","author":"Lattanzi","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0525","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115211_bb0530","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ymthe.2022.02.026","article-title":"Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells","volume":"30","author":"El-Kharrag","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115211_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115026","article-title":"Gene editing therapeutics based on mRNA delivery","volume":"200","author":"Popovitz","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0540","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/s41565-024-01765-4","article-title":"Acid-degradable lipid nanoparticles enhance the delivery of mRNA","volume":"19","author":"Zhao","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115211_bb0545","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"issue":"6656","key":"10.1016\/j.jconrel.2026.115211_bb0550","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.115211_bb0555","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1182\/blood-2024-208840","article-title":"Ex vivo expansion of human hematopoietic stem cells via lipid nanoparticle-mediated HOXB4 mRNA delivery","volume":"144","author":"Perveen","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115211_bb0560","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41587-024-02470-2","article-title":"Lipid nanoparticle-mediated mRNA delivery to CD34(+) cells in rhesus monkeys","volume":"43","author":"Kim","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0565","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12033-024-01070-4","article-title":"The future of gene therapy: a review of in vivo and ex vivo delivery methods for genome editing-based therapies","volume":"67","author":"Volodina","year":"2025","journal-title":"Mol. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0570","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"issue":"26","key":"10.1016\/j.jconrel.2026.115211_bb0575","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6893","article-title":"Impact of mRNA chemistry and manufacturing process on innate immune activation","volume":"6","author":"Nelson","year":"2020","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0580","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41551-021-00842-6","article-title":"Rapid manufacturing of non-activated potent CAR T cells","volume":"6","author":"Ghassemi","year":"2022","journal-title":"Nat. Biomed. Eng."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2026.115211_bb0585","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-1759(03)00010-3","article-title":"T cell stimulation and expansion using anti-CD3\/CD28 beads","volume":"275","author":"Trickett","year":"2003","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115211_bb0590","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nsmb.2212","article-title":"Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2","volume":"19","author":"Buis","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"14","key":"10.1016\/j.jconrel.2026.115211_bb0595","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.M808906200","article-title":"Human CtIP mediates cell cycle control of DNA end resection and double strand break repair","volume":"284","author":"Huertas","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115211_bb0600","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.4049\/jimmunol.1901396","article-title":"Efficient CRISPR\/Cas9 gene editing in uncultured naive mouse T cells for in vivo studies","volume":"204","author":"N\u00fcssing","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2026.115211_bb0605","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.omtn.2022.01.004","article-title":"Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages","volume":"27","author":"Moradian","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0610","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41598-018-36910-2","article-title":"Delivery of mRNA to platelets using lipid nanoparticles","volume":"9","author":"Novakowski","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115211_bb0615","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1182\/bloodadvances.2021004259","article-title":"Mitochondrial localization and moderated activity are key to murine erythroid enucleation","volume":"5","author":"Liang","year":"2021","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115211_bb0620","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1021\/acsbiomedchemau.4c00057","article-title":"Ex vivo delivery of mRNA to immune cells via a nonendosomal route obviates the need for nucleoside modification","volume":"4","author":"Ghoshal","year":"2024","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.jconrel.2026.115211_bb0625","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.2147\/IJN.S424723","article-title":"Delivery of plasmid DNA by ionizable lipid nanoparticles to induce CAR expression in T cells","volume":"18","author":"Prazeres","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202501475","article-title":"Co-delivery of multiple RNAs via lipid nanoparticles enables precise gene editing of CAR-T cells","volume":"15","author":"Wang","year":"2026","journal-title":"Adv. Healthc. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115211_bb0635","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1007\/s12274-024-6978-6","article-title":"mRNA medicine: recent progresses in chemical modification, design, and engineering","volume":"17","author":"Hou","year":"2024","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2026.115211_bb0640","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.omtn.2018.04.019","article-title":"Self-amplifying replicon RNA delivery to dendritic cells by cationic lipids","volume":"12","author":"Englezou","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"38","key":"10.1016\/j.jconrel.2026.115211_bb0645","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505718122","article-title":"Circular RNA lipid nanoparticle vaccine against SARS-CoV-2","volume":"122","author":"Swingle","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"20","key":"10.1016\/j.jconrel.2026.115211_bb0650","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2302191120","article-title":"Circular RNA vaccine induces potent T cell responses","volume":"120","author":"Amaya","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0655","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41467-018-05079-7","article-title":"Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude","volume":"9","author":"Brenner","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0660","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12951-022-01544-0","article-title":"Modularity of RBC hitchhiking with polymeric nanoparticles: testing the limits of non-covalent adsorption","volume":"20","author":"Lenders","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115211_bb0665","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12865-021-00435-7","article-title":"Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy","volume":"22","author":"Ghaffari","year":"2021","journal-title":"BMC Immunol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:58:59Z","timestamp":1790211539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":133,"alternative-id":["S0168365926006152"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115211","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering the blood: Lipid nanoparticle platforms for ex vivo immune and hematopoietic cell therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115211"}}